Annovis Bio
A clear Webflow site for a Phase 3 biotech, presenting its neurodegeneration programs, drug pipeline and news to patients and investors.
ClientAnnovis Bio, Inc.
LocationMalvern, Pennsylvania, USA
ServicesWeb Design · Webflow Build
PlatformWebflow
lockannovisbio.com
Explaining a Phase 3 pipeline to every audience
Annovis Bio (NYSE: ANVS) is a Phase 3 clinical-stage company developing buntanetap, an investigational once-daily oral therapy for Alzheimer's and Parkinson's diseases. Its site serves patients, researchers and investors at once, so it had to explain the science simply, show pipeline progress honestly and keep news and investor information easy to reach.
We used a calm navy and white system with the logo's red as an accent. Program cards split Alzheimer's, Parkinson's and other disorders, and a custom pipeline chart tracks each indication from pre-clinical to OLE. A photo-backed stats band frames the scale of the diseases, followed by dated news cards and a newsletter signup.
Pipeline progress chart
Each indication and combination therapy tracked across clinical phases.
Disease program cards
Alzheimer's, Parkinson's and other disorders, each with its own page.
Disease impact stats
Key prevalence and trial figures set over a full-width photo.
Latest news feed
Dated press release cards linking to the full archive.
The challenge, in numbers
Phase 3Clinical stage of buntanetap
7MAmericans living with Alzheimer's
1MAmericans living with Parkinson's
Inside the build
annovisbio.comnorth_east
About and programs
Drug pipeline
Disease statistics
Latest news
Next projectARTS
arrow_forwardWant results like Annovis Bio?
Tell us where you want to grow. We'll come back with a plan within one business day.
Let's talkarrow_forward